(Q48099005)

8 February 2018

title

How to increase value and reduce waste when research priorities are set. (English)

1 reference

8 February 2018

How to increase value and reduce waste when research priorities are set (English)

0 references

1 reference

8

John P A Ioannidis

1 reference

8 February 2018

Jonathan Grant

5

0 references

David Howells

object named as

David W Howells

7

0 references

Iain Chalmers

1

object named as

Iain Chalmers

1 reference

8 February 2018

6

A Metin Gülmezoglu

1 reference

8 February 2018

author name string

Michael B Bracken

2

1 reference

8 February 2018

Ben Djulbegovic

3

1 reference

8 February 2018

Silvio Garattini

4

1 reference

8 February 2018

Sandy Oliver

9

1 reference

8 February 2018

Iain Chalmers

1

0 references

Jonathan Grant

5

0 references

David W Howells

7

0 references

language of work or name

English

0 references

publication date

8 January 2014

1 reference

8 February 2018

January 2014

0 references

published in

The Lancet

1 reference

8 February 2018

volume

383

1 reference

8 February 2018

issue

9912

1 reference

8 February 2018

page(s)

156-165

1 reference

8 February 2018

The scandal of poor medical research

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Avoidable waste in the production and reporting of research evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Biomedical research: increasing value, reducing waste

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Funding for practice-oriented clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

1 reference

7 January 2021

Scientific basis for the support of biomedical science

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Comroe and Dripps revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Basic research and health: a reassessment of the scientific basis for the support of biomedical science

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Medicine. Life cycle of translational research for medical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The answer is 17 years, what is the question: understanding time lags in translational research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Wanted: better benchmarks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

More time for research: Fund people not projects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

U.S. science policy. White House panel urges agencies to take more risks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The philosophical basis of peer review and the suppression of innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Research grants: Conform and be funded

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Evidence in agenda setting: new directions for the Cochrane Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

NIH disease funding levels and burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Need to realign patient-oriented and commercial and academic research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Relation between agendas of the research community and the research consumer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Ethics in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Improving the translational hit of experimental treatments in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Meta-analysis of data from animal studies: a practical guide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Medical research: Trial unpredictability yields predictable therapy gains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Increasing value and reducing waste in research design, conduct, and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Believe it or not: how much can we rely on published data on potential drug targets?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Drug development: Raise standards for preclinical cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Expectations, validity, and reality in omics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

1 reference

7 January 2021

Identifying research needs for improving health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Qualitative studies of stroke: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

A systematic examination of the citation of prior research in reports of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The use of systematic reviews when designing studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

What are the implications of optimism bias in clinical research?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Optimism bias leads to inconclusive results-an empirical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Reference bias in reports of drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

How citation distortions create unfounded authority: analysis of a citation network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Is clinical research still too haphazard?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Establishing risk of human experimentation with drugs: lessons from TGN1412.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: Discussion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Passive smoking and lung cancer: a cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Meta-analyses of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Empirical evaluation of very large treatment effects of medical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Increasing value and reducing waste: addressing inaccessible research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

If a job is worth doing, it is worth doing twice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Developing core outcome sets for clinical trials: issues to consider

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Democratizing clinical research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Involving burn survivors in agenda setting on burn research: an added value?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The James Lind Alliance approach to priority setting for prostate cancer research: an integrative methodology based on patient and clinician participation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

'But is it a question worth asking?' A reflective case study describing how public involvement can lead to researchers' ideas being abandoned.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Public involvement in setting a national research agenda: a mixed methods evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

What Factors Predict Scientists' Intentions to Participate in Public Engagement of Science Activities?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Patients' and clinicians' research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Expediting systematic reviews: methods and implications of rapid reviews.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

The automation of systematic reviews.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Reducing waste from incomplete or unusable reports of biomedical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

An international registry of systematic-review protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Preregistration of epidemiology protocols: a commentary in support

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Registering observational research: second thoughts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

Progress in using systematic reviews of animal studies to improve translational research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962229-1

7 January 2021

10.1016/S0140-6736(13)62229-1

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018